| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/10/2008 | US7385063 Method for preparing imidazole derivatives |
| 06/10/2008 | US7385024 For therapy of proliferative diseases (particularly cancer), acromegaly or diabetic nephropathies and retinopathies |
| 06/10/2008 | US7384976 Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use |
| 06/10/2008 | US7384967 Aryl carbonyl derivatives as therapeutic agents |
| 06/10/2008 | US7384963 2′-Methyl-5-(1,3,4-oxadiazol-2-yl)1, 1′-biphenyl-4-carboxaide derivatives and their use as p38 kinase |
| 06/10/2008 | US7384958 Quinoline inhibitors of cGMP phosphodiesterase |
| 06/10/2008 | US7384957 3,4-dihydro-1H-isoquinolin-2-yl-derivatives |
| 06/10/2008 | US7384950 Respiratory system disorders; asthma; chronic obstructive pulmonary disease |
| 06/10/2008 | US7384943 Substituted chroman derivatives |
| 06/10/2008 | US7384942 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 06/10/2008 | US7384937 Antiarthritic agents; multiple sclerosis ; organ rejection ; antidiabetic agents; inflammatory bowel disorders; antiischemic agents; skin disorders |
| 06/10/2008 | US7384936 Carboxamidine derivatives and their use in the treatment of vascular diseases |
| 06/10/2008 | US7384932 bradycardial agent, myocardial ischaemia, angina pectoris, myocardial infarct and associated rhythm disturbances, supraventricular rhythm disturbances, and heart failure; mixture of acetonitrile and water is preheated, ivabradine hydrochloride is added, cooled at room temperature |
| 06/10/2008 | US7384925 2' Hydroxy-3'-bromo-3,4,4',5-tetramethoxy-(Z)-stilbene; antimitotic agent; inhibits the assembly of tubulin into microtubules; anticarcinogenic: solid tumor cancers, neovascularization; tubulin-binding stilbenoid analogs structurally related to combretastatin A-1 and A-4 (extract from willow tree) |
| 06/10/2008 | US7384917 oligopeptides having renin suppression, diuretic and/or vasodilator activity in mammals; treating congestive heart failure |
| 06/10/2008 | US7384756 Methods for treating muscle diseases and disorders |
| 06/10/2008 | US7384632 for prevention and/or treatment of cellular degeneration, including nerve cell damage associated with acute nervous cell system injury and chronic neurodegenerative diseases, including peripheral neuropathy |
| 06/10/2008 | US7384418 Methods and devices for delivery of agents to breast milk ducts |
| 06/10/2008 | CA2429590C Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 06/10/2008 | CA2427338C Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| 06/10/2008 | CA2393995C Novel benzene sulfonamide derivatives, their preparation and pharmaceutical compositions containing them |
| 06/10/2008 | CA2376121C Stable xylometazoline and oxymetazoline solution |
| 06/10/2008 | CA2369070C 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof |
| 06/10/2008 | CA2365826C Over-coated chewing gum formulations |
| 06/10/2008 | CA2329234C Controlled release peroral compositions of levosimendan |
| 06/10/2008 | CA2325933C Fatty acid derivatives of bile acids and bile acid derivatives |
| 06/10/2008 | CA2311530C Nasal solutions |
| 06/10/2008 | CA2310028C High drug load immediate and modified release oral dosage formulations and processes for their manufacture |
| 06/10/2008 | CA2296665C Triazolo[4,5-d]pyrimidine derivatives as anti-thromobotic agents |
| 06/05/2008 | WO2008067465A1 Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
| 06/05/2008 | WO2008067079A2 Method and apparatus to identify vulnerable plaques with thermal wave imaging of heated nanoparticles |
| 06/05/2008 | WO2008066886A2 Muscle derived cells for the treatment of cardiac pathologies and methods of making and using the same |
| 06/05/2008 | WO2008066494A1 THERAPEUTIC USES OF β-ANTAGONISTS |
| 06/05/2008 | WO2008066297A1 Pharmaceutical composition for treatment and prevention of restenosis |
| 06/05/2008 | WO2008066145A1 Thiazole derivative and use thereof as vap-1 inhibitor |
| 06/05/2008 | WO2008065754A1 Substituted carbinol compound |
| 06/05/2008 | WO2008065636A2 Treatment of disease by modulating cf5 protein |
| 06/05/2008 | WO2008065503A1 (r) -5-methyl-4, 5-dihydro- pyrazole-1, 5-dicarboxylic acid 1- [ ( 4 -chlorophenyl) amide 5-{ [2-fluoro-4- (2-oxo-2h-pyridin-1-yl) -phenyl]amide) as a factor xa inhibitor |
| 06/05/2008 | WO2008065431A1 Ramipril-amine salts |
| 06/05/2008 | WO2008065424A1 Ramipril-amlodipine salt |
| 06/05/2008 | WO2008065421A1 Ramipril-metal salts |
| 06/05/2008 | WO2008065417A1 Ramipril-amino acid salts |
| 06/05/2008 | WO2008065044A1 Use of phosphoenolpyruvate derivatives for treating necrosis of cardiac muscle tissue |
| 06/05/2008 | WO2008064916A2 Agent for treating vascular leaks |
| 06/05/2008 | WO2008064789A1 Substituted 4-amino-3,5-dicyano-2-thiopyridines and use thereof |
| 06/05/2008 | WO2008064788A1 Cyclically substituted 3,5-dicyano-2-thiopyridines and use thereof |
| 06/05/2008 | WO2008064592A1 A composition comprising chinese traditional medicine as active ingredient for treating cardiovascular diseases and quality control method thereof |
| 06/05/2008 | WO2008020275B1 Replacing heart surgery by micronutrient |
| 06/05/2008 | US20080132704 3-Substituted quinuclidines and their use |
| 06/05/2008 | US20080132574 Leukotriene B4 receptor binding activity; treatment of skin disease such as psoriasis, eczema, skin cancer, keratosis, dyspigmentation or psilosis |
| 06/05/2008 | US20080132561 Materials and Methods for Treating Hypercholesterolemia |
| 06/05/2008 | US20080132555 Preparation and utility of substituted phenyltetrazoles |
| 06/05/2008 | US20080132554 Crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
| 06/05/2008 | US20080132542 [5-(5-{4-[2-(Trifluoromethyl)phenoxy]piperidin-1-yl}-1,3,4-thiadiazol-2-yl)-2H-tetrazol-2-yl]acetic acid; metabolic disorders,antidiabetic, hypoglycemic agent; obesity, insulin resistance, liver steatosis, atherosclerosis, neurological disease, dyslipidemia, hyperlipidemia, low HDL, and high LDL |
| 06/05/2008 | US20080132521 Isoquinolinone Derivatives and Their Use As Therapeutic Agents |
| 06/05/2008 | US20080132507 Hydrazide Derivatives |
| 06/05/2008 | US20080132483 Administering (3R,5S)-N-propanesulfonyl-7-chloro-5-(2,3-dimethoxyphenyl)-1-(3-hydroxy-2,2-dimethylpropyl)-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-acetamide; cerebral infarction |
| 06/05/2008 | US20080132479 Oxime Derivative and Preparations Thereof |
| 06/05/2008 | US20080132476 Administering e.g. 17beta-Fluoro-9alpha-vinyl-estra-1,3,5(10)-triene-3,16alpha-diol to treat endometriosis, osteoporosis, or hormone replacement therapy in combination with other drugs |
| 06/05/2008 | US20080132471 Administering a derivative of alendronate or pamidronate and a mucosal membrane protecting agent; osteoporosis, osteopenia, urolithiasis, hypercalcemia, Paget's disease, bone metastasis, multiple myeloma, or neoplastic bone lesion |
| 06/05/2008 | US20080132454 bioavailable ACE-inhibiting peptides that are absorbed intact; protein hydrolysate; hydrolyzing the casein fraction using a protease, subtilisin; foods, beverages |
| 06/05/2008 | US20080132450 Pharmaceutical composition for suppression of apoptosis and method for delivering the same |
| 06/05/2008 | US20080131565 Edible composition; partially defatted cocoa solids prepared by heating slaty and/or purple cocoa beans, winnowing the cocoa nibs from the cocoa shells; pressing the cocoa nibs to produce cocoa butter, recovering the cocoa butter and solids; adding the recovered, defatted cocoa solids |
| 06/05/2008 | US20080131534 Use of a plant extract or plant juice |
| 06/05/2008 | US20080131475 Stenosis, restenosis; active agent polymer matrix coated stents; easy adaptation of required drug release rate |
| 06/05/2008 | US20080131474 Promoting cardiac tissue repair while inhibiting or reducing vascular occlusion and/or restenosis |
| 06/05/2008 | US20080131472 Sulfated Depolymerized Derivatives of Exopolysaccharides (Eps) from Mesophilic Marine Bacteria, Method for Preparing Same, and Uses Thereof in Tissue Regeneration |
| 06/05/2008 | US20080131437 Using allelic variation in cell adhesion molecule (CD164) as tool in treatment and prevntion of skin, arthritic and gastrointestinal disorders |
| 06/05/2008 | US20080131426 Using kallikren specific immunoglobulin as therapeutic tool in treating cardiocascular disorders; tissue repair |
| 06/05/2008 | US20080131423 Triggering receptors expressed on myeloid cells (TREMs) specific immunoglobulin for use in prevention and treatment of blood coagulation disorders |
| 06/05/2008 | US20080131410 Placental stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
| 06/05/2008 | US20080131406 Angiotensin I Derivatives |
| 06/05/2008 | US20080131399 Using interferon alpha chimera to treat and prevent cell proliferative and viral diseases |
| 06/05/2008 | DE102006056766A1 Verwendung von kompatiblen Soluten Use of compatible solutes |
| 06/05/2008 | DE102006056740A1 Cyclisch substituierte 3,5-Dicyano-2-thiopyridine und ihre Verwendung Cyclic substituted 3,5-dicyano-2-thiopyridines and their use |
| 06/05/2008 | DE102006056739A1 Substituierte 4-Amino-3,5-dicyano-2-thiopyridine und ihre Verwendung Substituted 4-amino-3,5-dicyano-2-thiopyridines, and their use |
| 06/05/2008 | CA2671169A1 Agent for the treatment of vascular leaks |
| 06/05/2008 | CA2670957A1 Modulation of prostaglandin/cyclooxygenase metabolic pathways |
| 06/05/2008 | CA2670949A1 Muscle derived cells for the treatment of cardiac pathologies and methods of making and using the same |
| 06/05/2008 | CA2670776A1 Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
| 06/05/2008 | CA2670595A1 (r)-5-methyl-4,5-dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chlorophenyl)amide 5-{[2-fluoro-4-(2-oxo-2h-pyridin-1-yl)-phenyl)amide) as a fact or xa inhibitor |
| 06/04/2008 | EP1927368A2 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 06/04/2008 | EP1927365A1 A new bacillus subtilis strain and its use in preparing medicine for treating thrombosis |
| 06/04/2008 | EP1927352A2 Therapeutic methods and compositions involving isoflavones |
| 06/04/2008 | EP1927350A1 Methods for improving bioavailability of a renin inhibitor |
| 06/04/2008 | EP1926743A1 2-(AMINOMETHYL)-5-CHLOROBENZYLAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE CLOTTING FACTOR Xa |
| 06/04/2008 | EP1926729A1 Benzothiazole cyclobutyl amine derivatives and their use as histamine-3 receptors ligands |
| 06/04/2008 | EP1926727A1 4-chromenonyl-1,4-dihydropyridinecarbonitriles and the use thereof |
| 06/04/2008 | EP1737847B1 Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol |
| 06/04/2008 | EP1493033B1 Use of sc6 for diagnosis and treatment of breast carcinoma |
| 06/04/2008 | EP1487817B1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 06/04/2008 | EP1474119B1 Use of extracts containing phytoestrogen selectively modulating estrogen-receptor-beta |
| 06/04/2008 | EP1463754B1 Cystine-knot fold protein |
| 06/04/2008 | EP1456357B1 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
| 06/04/2008 | EP1448089A4 Devices and methods for the restoration of a spinal disc |
| 06/04/2008 | EP1392688B1 Pyrazino[1',2':1,6]-pyrido[3,4-b] indole-1,4-dione derivatives |
| 06/04/2008 | EP1343775B1 Piperazine derivatives |
| 06/04/2008 | EP1237887B1 9-(piperazinylalkyl)carbazoles as bax-modulators |
| 06/04/2008 | EP1019082B2 Use of a colony stimulating factor (csf) for enhancing collateral growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 06/04/2008 | CN101193913A Adiponectin variants |